Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Chinese Medical Journal|September 15, 2015
Ifosfamide, Cisplatin or Carboplatin, and Etoposide (ICE)-based Chemotherapy for Mobilization of Autologous Peripheral Blood Stem Cells in Patients with LymphomasPing Zhou, Peng Liu, Sheng-Yu Zhou, et al.
Journal of Cancer|October 12, 2019
Depth of Response was Associated with Progression-Free Survival in Patients with Advanced Non-small Cell Lung Cancer treated with EGFR-TKIYu-Tao Liu, Kai Zhang, Cheng-Cheng Li, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 3, 2009
[Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients]Yan Qin, Yuan-Kai Shi, Xiao-Hui He, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2018
Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung CancerYi-Long Wu, Shun Lu, You Lu, et al.
Chinese Journal of Cancer|May 30, 2012
R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphomaXiao-Hui He, Bo Li, Sheng Yang, et al.
Cancer Management and Research|July 2, 2020
Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled TrialYu-Tao Liu, Xue-Zhi Hao, De-Ruo Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2011
Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approachManuel Salto-Tellez, Ming-Sound Tsao, Jin-Yuan Shih, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 22, 2009
[A prospective multicenter study of rituximab combined with high-dose chemotherapy and autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma]Yuan-kai Shi, Sheng Yang, Xiao-hong Han, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2017
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell LymphomaUmberto Vitolo, Marek Trněný, David Belada, et al.
Thoracic Cancer|May 10, 2021
Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patientsLi-Ling Huang, Xing-Sheng Hu, Yan Wang, et al.
Pageof 9